These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19769624)

  • 21. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid.
    Mihailović M; Cvetković M; Ljubić A; Kosanović M; Nedeljković S; Jovanović I; Pesut O
    Biol Trace Elem Res; 2000 Jan; 73(1):47-54. PubMed ID: 10949968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments.
    Bigazzi M; Ronga R; Lancranjan I; Ferraro S; Branconi F; Buzzoni P; Martorana G; Scarselli GF; Del Pozo E
    J Clin Endocrinol Metab; 1979 Jan; 48(1):9-12. PubMed ID: 422709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].
    Chełchowska M; Lewandowski L; Ambroszkiewicz J; Swiatek E; Gajewska J; Ołtarzewski M; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):474-8. PubMed ID: 19189526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects.
    Brian SR; Bidlingmaier M; Wajnrajch MP; Weinzimer SA; Inzucchi SE
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3374-7. PubMed ID: 17595256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful pregnancy in an acromegalic patient during 2-Br-alpha-ergocryptine (CB-154) therapy.
    Miyakawa I; Taniyama K; Koike H; Mori N; Nagamine M; Kuribayashi T; Araki S
    Acta Endocrinol (Copenh); 1982 Nov; 101(3):333-8. PubMed ID: 7148332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful pregnancy in a woman with acromegaly treated with octreotide.
    Neal JM
    Endocr Pract; 2000; 6(2):148-50. PubMed ID: 11421531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Octreotide LAR treatment throughout pregnancy in an acromegalic woman.
    Fassnacht M; Capeller B; Arlt W; Steck T; Allolio B
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):411-5. PubMed ID: 11589686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy.
    Takano T; Saito J; Soyama A; Ito H; Iizuka T; Yoshida T; Nishikawa T
    Endocr J; 2006 Apr; 53(2):209-12. PubMed ID: 16618979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Octreotide treatment of acromegaly during pregnancy.
    Mikhail N
    Mayo Clin Proc; 2002 Mar; 77(3):297-8. PubMed ID: 11888040
    [No Abstract]   [Full Text] [Related]  

  • 30. Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding.
    Berthelsen BG; Fjeldsøe-Nielsen H; Nielsen CT; Hellmuth E
    Rheumatology (Oxford); 2010 Nov; 49(11):2225-7. PubMed ID: 20581374
    [No Abstract]   [Full Text] [Related]  

  • 31. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.
    Zelinkova Z; de Haar C; de Ridder L; Pierik MJ; Kuipers EJ; Peppelenbosch MP; van der Woude CJ
    Aliment Pharmacol Ther; 2011 May; 33(9):1053-8. PubMed ID: 21366638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development.
    Van Calsteren K; Amant F
    Verh K Acad Geneeskd Belg; 2011; 73(1-2):105-21. PubMed ID: 22276398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental passage of antiepileptic drugs at delivery and neonatal outcomes.
    Bank AM; Stowe ZN; Newport DJ; Ritchie JC; Pennell PB
    Epilepsia; 2017 May; 58(5):e82-e86. PubMed ID: 28387929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin control of placental gene expression shifts from mother to foetus over the course of pregnancy.
    Hiden U; Maier A; Bilban M; Ghaffari-Tabrizi N; Wadsack C; Lang I; Dohr G; Desoye G
    Diabetologia; 2006 Jan; 49(1):123-31. PubMed ID: 16344925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy in acromegaly: successful therapeutic outcome.
    Herman-Bonert V; Seliverstov M; Melmed S
    J Clin Endocrinol Metab; 1998 Mar; 83(3):727-31. PubMed ID: 9506716
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy.
    Newport DJ; Viguera AC; Beach AJ; Ritchie JC; Cohen LS; Stowe ZN
    Am J Psychiatry; 2005 Nov; 162(11):2162-70. PubMed ID: 16263858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report.
    Skajaa GO; Mathiesen ER; Iyore E; Beck-Nielsen H; Jimenez-Solem E; Damm P
    BMC Res Notes; 2014 Nov; 7():804. PubMed ID: 25404386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethambutol in pregnancy--foetal exposure.
    Shneerson JM; Francis RS
    Tubercle; 1979 Sep; 60(3):167-9. PubMed ID: 516170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heavy metals and placental fetal-maternal barrier: a mini-review on the major concerns.
    Caserta D; Graziano A; Lo Monte G; Bordi G; Moscarini M
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2198-206. PubMed ID: 23893187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-generation somatostatin receptor ligands and pregnancy: lesson from women with acromegaly.
    Vialon M; Grunenwald S; Mouly C; Vezzosi D; Bennet A; Caron P
    Endocrine; 2020 Nov; 70(2):396-403. PubMed ID: 32734551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.